For: | Kim B, Kim Y, Park I, Cho JY, Lee KA. Detection of EGFR-SEPT14 fusion in cell-free DNA of a patient with advanced gastric cancer: A case report . World J Clin Cases 2021; 9(12): 2884-2889 [PMID: 33969073 DOI: 10.12998/wjcc.v9.i12.2884] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i12/2884.htm |
Number | Citing Articles |
1 |
Sohyun Hwang, Seonjeong Woo, Beodeul Kang, Haeyoun Kang, Jung Sun Kim, Sung Hwan Lee, Chang Il Kwon, Dong Soo Kyung, Hwang-Phill Kim, Gwangil Kim, Chan Kim, Hong Jae Chon. Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer. Journal of Hepatology 2025; 82(4): 649 doi: 10.1016/j.jhep.2024.10.020
|
2 |
Boyeon Kim, Yoonjung Kim, Jae Yong Cho, Kyung-A Lee. Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer. Annals of Laboratory Medicine 2024; 44(2): 164 doi: 10.3343/alm.2023.0187
|
3 |
Shengnan Zheng, Huiying Li, Jie Feng, Cheng Jiang, Yongjuan Lin, Yu Xie, Tingting Yu, Xiaoping Qian, Zhenyu Yin. Complete remission in leptomeningeal metastasis of NSCLC with rare EGFR-SEPT14 fusion treated with osimertinib combined with intrathecal chemotherapy with pemetrexed. Anti-Cancer Drugs 2022; 33(1): e795 doi: 10.1097/CAD.0000000000001222
|
4 |
Mary Luz Uribe, Ilaria Marrocco, Yosef Yarden. EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. Cancers 2021; 13(11): 2748 doi: 10.3390/cancers13112748
|
5 |
|